Related Experiment Video
Updated: Aug 13, 2026

Two- and Three-Dimensional Live Cell Imaging of DNA Damage Response Proteins
Published on: September 28, 2012
Binding of human single-stranded DNA binding protein to DNA damaged by the anticancer drug
C K Clugston1, K McLaughlin, M K Kenny
1CRC Department of Medical Oncology, CRC Beatson Laboratories, Glasgow, Scotland.
Abstract:
The chemotherapeutic drug cis-diamminedichloroplatinum (II) covalently binds to DNA resulting in a variety of adducts and cross-links which are thought to be responsible for the toxicity of the drug. We have used the gel mobility shift assay to detect proteins which bind to DNA treated in vitro with cis-diamminedichloroplatinum (II) and have identified two complexes which bind with increased affinity to cis-diamminedichloroplatinum (II)-damaged DNA. Using monoclonal antibodies we have shown that one complex, B1, contains human single-stranded DNA binding protein, a protein known to be involved in the in vitro repair synthesis assay of mammalian excision repair.
Insights
Researchers identified two protein complexes that bind to DNA damaged by cis-diamminedichloroplatinum (II), a chemotherapy drug. One complex (B1) contains human single-stranded DNA binding protein, crucial for DNA repair.
Area of Science:
- Molecular Biology
- Biochemistry
- Cancer Research
Background:
- Cis-diamminedichloroplatinum (II) (cisplatin) is a widely used chemotherapeutic agent.
- Cisplatin exerts its cytotoxic effects by covalently binding to DNA, forming various adducts and cross-links.
- The precise mechanisms by which cisplatin-DNA adducts are recognized and processed by cellular machinery are not fully understood.
Purpose of the Study:
- To identify proteins that specifically bind to DNA damaged by cisplatin.
- To characterize the nature of these protein-DNA interactions in vitro.
- To investigate the potential role of these proteins in DNA repair pathways.
Main Methods:
- Treatment of DNA in vitro with cis-diamminedichloroplatinum (II).
- Gel mobility shift assay to detect protein-DNA interactions.
- Western blot analysis using monoclonal antibodies to identify specific proteins within the complexes.
Main Results:
- Two distinct protein-DNA complexes with increased affinity for cisplatin-damaged DNA were identified.
- One complex, designated B1, was found to contain the human single-stranded DNA binding protein (HSSB).
- HSSB is known to be involved in mammalian DNA excision repair synthesis.
Conclusions:
- Cisplatin-damaged DNA recruits specific protein complexes, including HSSB.
- The identification of HSSB in complex with damaged DNA suggests its involvement in the cellular response to cisplatin-induced DNA lesions.
- These findings contribute to understanding the molecular mechanisms of cisplatin chemotherapy and DNA repair.
Related Concept Videos
DNA Helicases
Fixing Double-strand Breaks
DNA Damage can Stall the Cell Cycle
Homologous Recombination
Single-Strand DNA Binding Proteins
DNA Damage Can Stall the Cell Cycle

